NewsClick

NewsClick
  • हिन्दी
  • Politics
  • Economy
  • Covid-19
  • Science
  • Culture
  • India
  • International
  • Sports
  • Articles
  • Videos
search
menu

SUBSCRIBE AND SUPPORT

image/svg+xml
  • All Articles
  • Newsclick Articles
  • All Videos
  • Newsclick Videos
  • हिन्दी
  • Politics
  • Economy
  • Science
  • Culture
  • India
  • Sports
  • International
  • Africa
  • Latin America
  • Palestine
  • Nepal
  • Pakistan
  • Sri Lanka
  • US
  • West Asia
About us
Grievance Redressal Mechanism
Newsletter
Facebook - Newsclick Twitter - Newsclick Instagram - Newsclick Youtube - Newsclick RSS - Newsclick
close menu
×
You deserve independent, critical media. Subscribe and Support
Politics
India

WHO to Meet Next Week to Consider Emergency Use Listing of India’s Covaxin

The technical advisory group will meet on October 26 to consider EUL for Bharat Biotech’s Vaccine, says Soumya Swaminathan.
PTI
18 Oct 2021
WHO

United Nations/Geneva: The World Health Organisation’s technical advisory group will meet on October 26 to consider the emergency use listing of India’s Covaxin, which is being used in the country's nationwide anti-COVID-19 vaccination programme, according to the global health agency's chief scientist Soumya Swaminathan.

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for its vaccine.

Swaminathan, the WHO's Chief Scientist, said on Twitter on Sunday that the technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) for Covaxin.

“@WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use and to expand access to populations everywhere," she said in the tweet.

Earlier this month, WHO said that Bharat Biotech “has been submitting data to WHO on a rolling basis and submitted additional information at the WHO's request on September 27. The WHO experts are currently reviewing this information and if it addresses all questions raised, the WHO assessment will be finalised next week."

The Geneva-based WHO said it began rolling data of the vaccine on July 6. Rolling data allows the WHO to start its review right away, as information continues to come in to accelerate the overall review process.

According to WHO, submissions for pre-qualification or listing under the emergency use procedure are confidential.

If a product submitted for assessment is found to meet the criteria for listing, the WHO will publish the results widely.

Duration of the emergency use listing process depends on the quality of the data submitted by the vaccine manufacturer and on the data meeting the WHO's criteria, according to the agency.

The indigenously-developed Bharat Biotech's Covaxin is one of the six vaccines that have received emergency use authorisation from India's drug regulator Drugs Controller General of India (DGCI) and is being used in the nationwide anti-COVID-19 inoculation programme along with Covishield and Sputnik V.

Bharat Biotech recently said it has submitted all data pertaining to Covaxin to the WHO for the EUL and is awaiting feedback from the global health watchdog.

"#COVAXIN clinical trial data was fully compiled and available in June 2021. All Data submitted for Emergency Use Listing (EUL) Application to World Health Organization in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback," Bharat Biotech had tweeted last month.

"We are diligently working with the WHO to obtain EUL at the earliest,” the company had said on Tuesday.

India, the world's largest producer of vaccines, suspended exports of COVID-19 vaccines in April to focus on inoculating its own population following a sudden spike in infections.

Last month, Union Health Minister Mansukh Mandaviya announced that India will resume the supplies abroad.

According to Johns Hopkins University, the coronavirus has claimed 4,897,386 lives along with 240,559,605 confirmed cases across the world so far.

Get the latest reports & analysis with people's perspective on Protests, movements & deep analytical videos, discussions of the current affairs in your Telegram app. Subscribe to NewsClick's Telegram channel & get Real-Time updates on stories, as they get published on our website.
WHO
Covaxin
EUL
Bharat Biotech
Covaxin Approval
Related Stories
Last rites of people who died due to Covid-19 are being performed

WHO Report on COVID-19 Excess Deaths: Modi Government’s Attempt to Shoot the Messenger

Make WHO-Recommended New COVID-19 Drugs Accessible, Affordable: MSF

COVID Deaths Dropped by 21% Last Week but Cases Rising Globally: WHO

COVID-19: WHO Says India had 4.7 Million Deaths; India Questions Model Used

COVID-19: WHO Says India had 4.7 Million Deaths; India Questions Model Used

2 Omicron Subvariants Can Escape Immunity from Previous Infection, Vaccines

2 Omicron Subvariants Can Escape Immunity from Previous Infection, Vaccines

covid 19 testing bihar.

India’s Objections to WHO Study on COVID-19 Mortality Assessment Appear Untenable

Covaxin

WHO’s Suspension of Covaxin Could be Hindrance for India’s Vaccine Programme

COVID-19 Cases Rise for Second Straight Week Globally, Deaths Fall: WHO

COVID-19 Cases Rise for Second Straight Week Globally, Deaths Fall: WHO

‘Recovery Trial’ Finds Anti-Arthritis Drug that Reduces Severe COVID-19 Mortality

‘Recovery Trial’ Finds Anti-Arthritis Drug that Reduces Severe COVID-19 Mortality

Top COVID-19 Vaccine Manufacturers Fail Poor Countries

Top COVID-19 Vaccine Manufacturers Fail Poor Countries

It was a Tough Battle, but we Fought it Well, Says Shailaja, Face of Kerala’s Initial Fight with COVID-19

It was a Tough Battle, but we Fought it Well, Says Shailaja, Face of Kerala’s Initial Fight with COVID-19

Share on FacebookShare on TwitterShare on WhatsAppShare via EmailShare on RedditShare on KindlePrint
Share
Share on FacebookShare on TwitterShare on WhatsAppShare via EmailShare on RedditShare on KindlePrint
Share
You deserve independent, critical media. We want readers like you. Support independent, critical media. Subscribe to Newsclick.

Subscribe and Support


Latest

  • crprt

    National Convention for Working Women Resolves to Strengthen Organisation in New Sectors

  • Delhi Sanitation Workers Demand Permanent Jobs

    Delhi Sanitation Workers Demand Permanent Jobs

  • DU Asks Colleges to Stop Recruitment in Absence of Regular Principals; Staff, Teachers Decry Move

    DU Asks Colleges to Stop Recruitment in Absence of Regular Principals; Teachers Protest

  • UP: After Backlash, Govt Says 'No Order’ for Surrender,  Cancellation of Ration Cards

    UP: After Backlash, Govt Says 'No Order’ for Surrender, Cancellation of Ration Cards

  • Load More
Newsletter
About us
Grievance Redressal Mechanism